Biotronik hits the market in Japan with Ilivia MRI-safe ICD
Biotronik said yesterday it launched its Ilivia magnetic resonance imaging-safe implantable cardioverter defibrillator in Japan. The Berlin-based comapny said the Ilivia device features both its ProMRI...
View ArticleEdwards Lifesciences’ CardiAQ Valve wants to add $23m to Neovasc’s $70m trade...
Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies wants a federal judge in Massachusetts to add 33%, or more than $23 million, to the $70 million trade theft verdict lodged against...
View ArticleFDA: No evidence of data manipulation in clinical trials for Bayer’s Essure
The FDA said it completed a review of a trade complaint which alleged that Bayer (ETR:BAYN) was engaged in clinical trial misconduct and altering data, saying it found no signs of manipulation. The...
View ArticleInsulet taps ATS Automation Tooling for planned U.S. plant, beefs up...
Insulet (NSDQ:PODD) said today it inked a 5-year deal with ATS Automation Tooling Systems to construct an automated manufacturing assembly line for its products and announced a pair of new executive...
View ArticleCardinal Health to pay up to $310m for Navidea’s LymphoSeek
Navidea (NYSE:NAVB) said today it inked a letter of intent with Cardinal Health (NYSE:CAH) to sell its Lymphoseek injection for up to $310 million. The sale includes all current FDA-approved...
View ArticleTiny ‘fitbits’ to keep tabs on the body from within
(Reuters) – Scientists are developing dust-sized wireless sensors implanted inside the body to track neural activity in real-time, offering a potential new way to monitor or treat a range of conditions...
View ArticleMassDevice.com +5 | The top 5 medtech stories for September 6, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleAlphatec closes $80m sale of int’l biz to Globus, announces 1-12 reverse split
Alphatec (NSDQ:ATEC) said it closed the $80 million sale of its international operations and distribution channels to Globus Medical (NYSE:GMED) and announced a 1-for-12 reverse stock split. Carlsbad,...
View ArticleDanaher to buy Cepheid in $4B deal to expand in diagnostics
(Reuters) –Danaher Corp. (NYSE:DHR) said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business. Danaher...
View ArticleTeleflex to close N.C. plant, lay off 104
Teleflex (NYSE:TFX) is looking to shutter a North Carolina facility, with plans to lay off 104 employees at the facility. The company’s Ashboro subsidiary Arrow said in May it had plans to lay off 84...
View ArticleOlympus sues ex-CEO whistleblower Woodford
(Reuters) – Olympus (TYO:7733), the Japanese medical equipment and camera maker, is suing former CEO and whistleblower Michael Woodford in a multimillion-pound legal row over allegations of wrongdoing...
View ArticleNatus Medical logs 1st $20m payment in $121m contract with Venezuela
Natus Medical (NSDQ:BABY) said today it received an initial $20 million payment as part of a $120.7 million supply agreement between the Ministry of Health of Venezuela and its Buenos Aires,...
View ArticleFresenius buys Spains largest private hospital chain for $6.4B
(Reuters) – German healthcare group Fresenius is buying Spain’s biggest private hospital chain Quironsalud for 5.8 billion euros ($6.4 bln), including assumed debt, in its biggest takeover ever. The...
View ArticleInsulet plans $250m debt offering
Insulet (NSDQ:PODD) said yesterday that it plans to fund a new, automated U.S. plant in part with the proceeds from a $250 million debt offering. Billerica, Mass.-based Insulet, which makes the Omnipod...
View ArticleANVISA expands list of items not considered “health products”
By Stewart Eisenhart, Emergo Group Brazilian medical device regulator ANVISA has added several products used in laboratory settings to its list of items not deemed “health products” and therefore not...
View ArticleSt. Jude Medical levels lawsuit against short seller
St. Jude Medical (NYSE:STJ) said today that it sued the short seller and the hacking shop behind a report of alleged cybersecurity vulnerabilities that’s shaved 5% from its share price since August...
View ArticleCogentix lands $25m from Accelmed
Cogentix Medical (NSDQ:CGNT) said today it inked a $25 million securities purchase agreement with Accelmed Growth Partner. Through the deal, Accelmed will buy $25 million in Cogentix Medical common...
View ArticleParents file lawsuit against Mylan over EpiPen ‘price-gouging’
A parent in Ohio reportedly leveled a class-action lawsuit against EpiPen maker Mylan (NSDQ:MYL) over the nearly 500% increase in the cost of the epinephrine injector since Mylan acquired the device in...
View ArticleBluewind Medical wins CE Mark for Vivendi mini-neurostim pain implant
Neurostim developer Bluewind Medical said today it won CE Mark approval in the European Union for its Vivendi neurostimulation device designed to treat peripheral neuropathic pain. The newly cleared...
View ArticleTransEnterix reboots ALF-X robot-assisted surgery platform as Senhance
TransEnterix (NYSE:TRXC) said today it is rebranding its ALF-X robotic surgical system as the Senhance surgical robotic system. The company said it made the switch to the new name and logo, which...
View Article